Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of sufentanil transdermal patch for cancer pain in tumor patients
CTR20250581Phase 2Active
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sufentanil in cancer pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Mar 2025; status: active.
02
Drugs
sufentanil
03
Conditions
cancer pain
Beyond the preview
Go deeper on CTR20250581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250581.